« Return to News Archives

Dr. Robert M. Honigberg Named URAC’s Chief Medical Officer

Monday, March 8th, 2010

Washington, D.C. – March 08, 2010URAC, the nation’s leading health care accreditation and education organization, today announced the appointment of Robert M. Honigberg, M.D., M.B.A, as Chief Medical Officer. In his role, Dr. Honigberg will advise on quality measurement and clinical effectiveness research and will lead global wellness and health promotion initiatives for URAC.

“We are pleased to have Robert as part of the URAC team. His in-depth knowledge of pharmaceutical research, medical technology, patient safety and medical communication will be invaluable as URAC continues to innovate and expand in the rapidly changing health care environment,” said Alan P. Spielman, president and CEO of URAC. “We have a long history of leveraging the best minds in the industry through our many accreditation committees and partnerships. It is exciting to have Robert continue that tradition for URAC.”

Reinforcing URAC’s commitment to continuous improvement in the quality and efficiency of health care management, Dr. Honigberg will also provide strategic direction for the organization’s research and measurement initiatives. This includes the new performance measures for URAC’s Mail Service and Specialty Pharmacy accreditation programs, which will be released later this year.

Dr. Honigberg brings more than 18 years of experience in global medical affairs, technology innovation, clinical and medical economic trials, and health policy. He currently serves as Chief Medical Advisor for several biotechnology companies as the principal of MS&T Consulting.

“I am thrilled to bring my experience in patient safety and medical risk assessment process to URAC to further the goal of consumer protection and empowerment,” said Dr. Honigberg. “Having led medical affairs for large companies, I know the value of measurable quality and clear benchmarks for success. Today’s health care environment needs the transparency and accountability that URAC accreditation brings.”

Dr. Honigberg was the Chief Medical Officer of Global Medical Affairs and Clinical Strategy at GE Healthcare. He was also the Vice President of Worldwide Medical Affairs and Chief Medical Officer for Ethicon Endo-Surgery, a Johnson & Johnson Company. In addition, Dr. Honigberg was Director of Clinical Affairs at Ortho Biotech, a Johnson & Johnson Company, and managed new business and product development for Schering-Plough’s Oncology/Biotech business unit.

Currently, Dr. Honigberg serves on the Board of Directors for the Center for International Health and is also a founding member of the Steering Committee for the Aspen Health Stewardship Project at the Aspen Institute in Washington, D. C.

Dr. Honigberg conducted his internship and residency at the Albert Einstein College of Medicine. He earned a B.A. in Economics from Duke University, an M.D. from the Feinberg School of Medicine and an M.B.A. from the Kellogg School of Management at Northwestern University.


For 25 years, URAC has been the independent leader in promoting health care quality through accreditation, education, and measurement. URAC offers a wide range of quality benchmarking programs that reflect the latest changes in health care and provide a symbol of excellence for organizations to showcase their validated commitment to quality and accountability. URAC’s evidence-based measures and standards are developed through inclusive engagement with a broad range of stakeholders committed to improving the quality of health care.

For more information about URAC, contact us.

Interested in accreditation?
Contact businessdevelopment@urac.org

Code of Conduct | Privacy Policy | Terms of Use

Social Media TextFollow us on FacebookFollow us on TwitterFollow us on Linked In